• Hydrocolloid layer reacts with cellular material from the wound to form a gel-like covering to help maintain a moist wound environment.
• Cohesive dressing removal system does not break down or leave residue in the wound and facilitates easy removal without tearing the dressing or skin. 
• Wound contact layer remains intact and minimizes potential wound bed disturbance.
• Cohesive dressing removal system does not break down or leave residue in the wound and facilitates easy removal without tearing the dressing or skin Wound contact layer remains intact and minimizes potential wound bed disturbance.
• Semi-transparent outer layer permits wound site visualization without removing dressing.
• Thin and flexible dressing conforms to body contours; adhesion is firm yet gentle to peri-wound skin.
• Highly absorbent inner layer effectively removes exudates from the wound and facilitates granulation, epithelialization, and autolysis.
• Moisture resistant outer barrier film helps prevent urine, feces and/or moisture from penetrating the dressing reducing the risk of contamination to the wound.
• Up to 7 day wear time provides undisturbed moist wound environment, enhances healing, minimizes skin maceration, and reduces frequency of dressing changes.
• Available in multiple shapes and sizes to fit caregiver needs including hard-to-dress areas such as the sacrum, heel, and elbow.
• Available with film-backing or foam-backing to suit various application needs.
• Single use 

McKesson Hydrocolloid Dressing Thin is indicated for the management of partial- and full-thickness wounds such as leg ulcers and pressure injuries. Helps maintain a moist wound healing environment to assist in autolytic debridement and protect the wound from external contamination.

Not intended for use on patients with known hypersensitivities to the components of the dressing or with third-degree burns. Conditions that led to the formation of the wound (pressure, venous insufficiency, etc) must be considered and addressed as part of the total wound care treatment plan. In the presence of infection, use may be continued in combination with appropriate antibiotic therapy and wound monitoring under medical supervision.